Loading...

Wednesday, May 18th



D. Juan José Hernández, President MD Anderson Cancer Center Madrid, Spain
Dr. Raúl Márquez, MD Anderson Cancer Center Madrid, Spain
Dr. F.Javier de Santiago, MD Anderson Cancer Center Madrid, Spain
Dr. Pedro T.Ramírez, MD Anderson Cancer Center, Houston, USA
Chairs:
Dr. Michael Frumovitz, MD Anderson Cancer Center, Houston, USA
Dr. Antonio Gil, Hospital Universitario Vall d'Hebron, Barcelona, Spain
10:45 - 11:05Conservative Management of Cervical Cancer: Impact of the ConCerv Trial
Dr. Pedro T. Ramírez, MD Anderson Cancer Center, Houston, USA
11:05 - 11:25Ideal Patient Selection for Radical Hysterectomy: Reconsidering Sedlis Criteria?
Dr. David Cibula, General University Hospital, Prague, Czech Republic
11:25 - 11:45Updates on Surgical Approach to Early-Stage Cervical Cancer
Dr. Pedro T. Ramírez, MD Anderson Cancer Center, Houston, USA
11:45 - 12:05Surgical Approach to Recurrent Cervical Cancer
Dr. Luis Chiva, Clínica Universidad de Navarra, Spain
12:05 - 12:25Updates on Persistent, Recurrent or Metastatic Cervical Cancer
Dr. Raúl Márquez, MD Anderson Cancer Center Madrid, Spain
12:25 - 12:55Questions and Panel Discussion
Chair:
Dr. Pedro T. Ramírez, MD Anderson Cancer Center, Houston, USA

Dr. David Cibula, General University Hospital, Prague, Czech Republic
Dr. Michael Frumovitz, MD Anderson Cancer Center, Houston, USA
Dr. Luis Chiva, Clínica Universidad de Navarra, Spain
Dr. David Cibula, General University Hospital, Prague
Dr. Ana Oaknin, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Chair:
Dr. Mansoor Mirza, Copenhagen University Hospital, Denmark
ESGO Guidelines in Endometrial Cancer Management
Dr. Nicole Concin, Medical University of Innsbruck, Austria
Chairs:
Dr. Mansoor Mirza, Copenhagen University Hospital, Denmark
Dr. Ana Oaknin, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
16:30 - 16:50Updates in Molecular Risk-Stratification
Dr. Shannon Westin, MD Anderson Cancer Center, Houston, USA
16:50 - 17:10Adjuvant Therapy for High-Risk Groups
Dr. Elena Villafranca, Complejo Hospitalario de Navarra, Pamplona, Spain
17:10 - 17:30Management of Recurrent Disease: Looking Beyond Chemotherapy
Dr. Mansoor Mirza, Conpenhagen University Hospital, Denmark
17:30 - 17:50Immunotherapy for Uterine Carcinoma: Is there any role at all?
Dr. Ana Oaknin, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
17:50 - 18:20Questions and Panel Discussion